CYP2D6-DEBRISOQUINE HYDROXYLASE GENE POLYMORPHISM IN MULTIPLE SYSTEM ATROPHY

被引：14
|
作者：
PLANTEBORDENEUVE, V
BANDMANN, O
WENNING, G
QUINN, NP
DANIEL, SE
HARDING, AE
机构：
[1] UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,NEUROGENET SECT,LONDON WC1N 3BG,ENGLAND
[2] UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,MOVEMENT DISORDERS SECT,LONDON WC1N 3BG,ENGLAND
[3] UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,PARKINSONS DIS SOC BRAIN BANK,LONDON WC1N 3BG,ENGLAND
来源：
MOVEMENT DISORDERS | 1995年 / 10卷 / 03期
关键词：
MULTIPLE SYSTEM ATROPHY; CYTOCHROME P450; PARKINSONS DISEASE;
D O I：
10.1002/mds.870100307
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Molecular genetic studies of the cytochrome P450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant yaffles in large series of patients with Parkinson's disease (PD) when compared with controls. We have investigated CYP2D6 polymorphism in 91 patients with multiple system atrophy (MSA) in order to determine if this finding is specific to PD or if there is similar evidence of genetic susceptibility to neurotoxicity in MSA. The distribution of CYP2D6 alleles was not significantly different between MSA patients and controls, and there were fewer poor metabolisers in the MSA group than in the control group.
引用
收藏
页码：277 / 278
页数：2
相关论文
共 50 条
  • [1] Debrisoquine hydroxylase gene polymorphism (CYP2D6*4) in dementia with Lewy bodies
    Huckvale, C
    Richardson, AMT
    Mann, DMA
    Pickering-Brown, SM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01): : 135 - 136
  • [2] Hydroxylation polymorphism of debrisoquine hydroxylase (CYP2D6) in patients with schizophrenia in Norway and Denmark
    Dahl, AA
    Lowert, A
    Asserson, S
    Bjarking, L
    Berglund, J
    Kristensen, F
    Norum, D
    Tonseth, S
    Bayer, L
    Maehlum, E
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (07) : 509 - 511
  • [3] Debrisoquine hydroxylase (CYP2D6) and prostate cancer
    Febbo, PG
    Kantoff, PW
    Giovannucci, E
    Brown, M
    Chang, G
    Hennekens, CH
    Stampfer, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (12) : 1075 - 1078
  • [4] IDENTIFICATION OF MUTATIONS IN THE CYP2D6 GENE THAT ALTER EXPRESSION OF DEBRISOQUINE-HYDROXYLASE
    MOIR, D
    SAXENA, R
    JONES, BF
    WEIFFENBACH, B
    CAPORASO, N
    RELLING, M
    EVANS, W
    SHAW, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 1740 - 1740
  • [5] THE DEMETHYLENATION OF METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) BY DEBRISOQUINE HYDROXYLASE (CYP2D6)
    TUCKER, GT
    LENNARD, MS
    ELLIS, SW
    WOODS, HF
    CHO, AK
    LIN, LY
    HIRATSUKA, A
    SCHMITZ, DA
    CHU, TYY
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) : 1151 - 1156
  • [6] DEBRISOQUINE HYDROXYLASE GENE POLYMORPHISM IN MENINGIOMA
    WUNDRACK, I
    MEESE, E
    MULLENBACH, R
    BLIN, N
    ACTA NEUROPATHOLOGICA, 1994, 88 (05) : 472 - 474
  • [7] DINUCLEOTIDE REPEAT POLYMORPHISM AT THE DEBRISOQUINE 4-HYDROXYLASE (CYP2D) LOCUS
    TROFATTER, JA
    GUSELLA, JF
    HAINES, JL
    NUCLEIC ACIDS RESEARCH, 1991, 19 (10) : 2802 - 2802
  • [8] Genetic polymorphism and Parkinson's disease in Taiwan: Study of debrisoquine 4-hydroxylase (CYP2D6)
    Lo, HS
    Chen, CH
    Hogan, EL
    Kao, KP
    Wang, VC
    Yan, SH
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (01) : 38 - 42
  • [9] Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia
    Jonsson, EG
    Dahl, ML
    Roh, HK
    Jerling, M
    Sedvall, GC
    PSYCHIATRIC GENETICS, 1998, 8 (01) : 25 - 28
  • [10] THE HUMAN DEBRISOQUINE 4-HYDROXYLASE (CYP2D) LOCUS - SEQUENCE AND IDENTIFICATION OF THE POLYMORPHIC CYP2D6 GENE, A RELATED GENE, AND A PSEUDOGENE
    KIMURA, S
    UMENO, M
    SKODA, RC
    MEYER, UA
    GONZALEZ, FJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1989, 45 (06) : 889 - 904
12345